Updated on 2023/03/10

写真a

 
BABA Taisuke
 
Organization
Nagoya University Hospital Gastroenterological Surgery 1 Assistant professor of hospital
Title
Assistant professor of hospital
External link

Degree 1

  1. Doctor of Philosophy (Medical Science) ( 2019.3   Nagoya University ) 

Research Interests 6

  1. Cholangiocarcinoma

  2. Pancreatic Cancer

  3. Bioinformatics

  4. Epigenetics

  5. Metabolomics

  6. AI

Research Areas 2

  1. Life Science / Tumor biology  / Pancreatic Cancer, Cholangiocarcinoma, Bioinfomatics, AI, Metabolomics, Epigenetics

  2. Life Science / Digestive surgery  / Pancreatic cancer, Cholangiocarcinoma

Current Research Project and SDGs 2

  1. Development of a novel machine learning model using non-target metabolomics for early cholangiocarcinoma detection

  2. 膵癌分子サブタイプの可塑性の解明とその作用機序に基づく新規診断治療法の開発

Research History 2

  1. Nagoya University   Nagoya University Hospital Gastroenterological Surgery 1   Assistant professor of hospital

    2022.4

  2. Harvard University, Massachusetts General Hospital   Department of Surgery   Researcher

    2019.4 - 2022.3

      More details

    Country:United States

Education 2

  1. Nagoya University   Surgical Oncology

    2015.4 - 2019.3

      More details

    Country: Japan

  2. Nagoya University

    2001.4 - 2007.3

      More details

    Country: Japan

 

Papers 7

  1. A lesson in transcriptional plasticity: Classical identity is silenced, but not lost, in pancreatic ductal adenocarcinoma cell lines. Reviewed International coauthorship International journal

    Taisuke Baba, Pascal Finetti; Pancreatic Cancer Group; Keith D Lillemoe, Andrew L Warshaw, Carlos Fernández-Del Castillo, Andrew S Liss

    Gastroenterology   Vol. 163 ( 5 ) page: 1450 - 1453   2022.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1053/j.gastro.2022.07.005

  2. Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer. Reviewed International journal

    Kano MT, Kokuryo T, Baba T, Yamazaki K, Yamaguchi J, Sunagawa M, Ogura A, Watanabe N, Onoe S, Miyata K, Mizuno T, Uehara K, Igami T, Yokoyama Y, Ebata T, Nagino M

    Anticancer research   Vol. 43 ( 3 ) page: 1009 - 1016   2023.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/anticanres.16245

    PubMed

  3. Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT). Reviewed International coauthorship International journal

    Bolm L, Zemskov S, Zeller M, Baba T, Roldan J, Harrison JM, Petruch N, Sato H, Petrova E, Lapshyn H, Braun R, Honselmann KC, Hummel R, Dronov O, Kirichenko AV, Klinkhammer-Schalke M, Kleihues-van Tol K, Zeissig SR, Rades D, Keck T, Fernandez-Del Castillo C, Wellner UF, Wegner RE.

    Cancers   Vol. 14 ( 4 ) page: 868   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/cancers14040868.

  4. ABO blood group distribution and risk of malignancy in patients undergoing resection for intraductal papillary mucinous neoplasm (IPMN). Reviewed International coauthorship International journal

    Zelga P, Hernández-Barco YG, Qadan M, Ferrone CR, Baba T, Bolm L, Jah A, Warshaw AL, Lillemoe KD, Balakrishnan A, Castillo CF.

    Pancreatology   Vol. 22 ( 2 ) page: 264 - 269   2021.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pan.2021.12.012.

  5. Evolving Trends in Pancreatic Cystic Tumors: A 3-Decade Single-Center Experience with 1290 Resections. Reviewed International coauthorship International journal

    Roldán J, Harrison JM, Qadan M, Bolm L, Baba T, Brugge WR, Casey BW, Krishnan K, Mino-Kenudson M, Pitman MB, Kambadakone A, Ferrone CR, Warshaw AL, Lillemoe KD, Castillo CF.

    Annals of Surgery   Vol. 277 ( 3 ) page: 491 - 497   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/SLA.0000000000005142

  6. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Reviewed International coauthorship International journal

    Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, Adrian Gottschlich, Justyna Ogonek, Bruno L. Cadilha, Zahra Dantes, Felicitas Rataj, Klara Dorman, Johannes Lutz, Clara H. Karches, Constanze Heise, Mathias Kurzay, Benjamin M. Larimer, Simon Grassmann, Moritz Rapp, Alessia Nottebrock, Stephan Kruger, Nicholas Tokarew, Philipp Metzger, Christine Hoerth, Mohamed-Reda Benmebarek, Dario Dhoqina, Ruth Grünmeier, Matthias Seifert, Arman Oener, Öykü Umut, Sandy Joaquina, Lene Vimeux, Thi Tran, Thomas Hank, Taisuke Baba, Duc Huynh, Remco T. A. Megens, Klaus-Peter Janssen, Martin Jastroch, Daniel Lamp, Svenja Ruehland, Mauro Di Pilato, Jasper N. Pruessmann, Moritz Thomas, Carsten Marr, Steffen Ormanns, Anna Reischer, Michael Hristov, Eric Tartour, Emmanuel Donnadieu, Simon Rothenfusser, Peter Duewell, Lars M. König, Max Schnurr, Marion Subklewe, Andrew S. Liss, Niels Halama, Maximilian Reichert, Thorsten R. Mempel, Stefan Endres & Sebastian Kobold

    Nature Biomedical Engineering   Vol. 5 ( 11 ) page: 1246 - 1260   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41551-021-00737-6.

  7. Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer. Reviewed International journal

    Baba T, Kokuryo T, Yamaguchi J, Yokoyama Y, Uehara K, Ebata T, Nagino M.

    Anticancer Research   Vol. 38 ( 3 ) page: 1427 - 1434   2018.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21873/anticanres.12367.

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 1

  1. 膵癌分子サブタイプの可塑性の解明とその作用機序に基づく新規診断治療法の開発

    Grant number:22K20819  2022.10 - 2024.3

    文部科学省  科学研究費助成事業  2022年度 研究活動スタート支援

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\2860000 ( Direct Cost: \2200000 、 Indirect Cost:\660000 )